152 related articles for article (PubMed ID: 20977315)
1. Significance of decoy receptor 3 in sera of hepatocellular carcinoma patients.
Yang M; Chen G; Dang Y; Luo D
Ups J Med Sci; 2010 Nov; 115(4):232-7. PubMed ID: 20977315
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma].
Chen G; Luo DZ; Wang Y; Liao ZL; Zhang MY
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):113-7. PubMed ID: 17493386
[TBL] [Abstract][Full Text] [Related]
3. Expression of decoy receptor 3 in liver tissue microarrays.
Chen G; Luo D
Natl Med J India; 2008; 21(6):275-8. PubMed ID: 19691215
[TBL] [Abstract][Full Text] [Related]
4. [Overexpression and genomic amplification of decoy receptor 3 in hepatocellular carcinoma and significance thereof].
Shen HW; Wu YL; Peng SY
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):744-7. PubMed ID: 12899749
[TBL] [Abstract][Full Text] [Related]
5. Elevated Serum Levels of the Antiapoptotic Protein Decoy-Receptor 3 Are Associated with Advanced Liver Disease.
Bamias G; Gizis M; Delladetsima I; Laoudi E; Siakavellas SI; Koutsounas I; Kaltsa G; Vlachogiannakos J; Vafiadis-Zouboulis I; Daikos GL; Papatheodoridis GV; Ladas SD
Can J Gastroenterol Hepatol; 2016; 2016():2637010. PubMed ID: 27595094
[TBL] [Abstract][Full Text] [Related]
6. Decoy receptor 3 (DcR3) overexpression predicts the prognosis and pN2 in pancreatic head carcinoma.
Zhou J; Song S; Li D; He S; Zhang B; Wang Z; Zhu X
World J Surg Oncol; 2014 Mar; 12():52. PubMed ID: 24597666
[TBL] [Abstract][Full Text] [Related]
7. DcR3, TFF3, and Midkine Are Novel Serum Biomarkers in Small Intestinal Neuroendocrine Tumors.
Edfeldt K; Daskalakis K; Bäcklin C; Norlén O; Tiensuu Janson E; Westin G; Hellman P; Stålberg P
Neuroendocrinology; 2017; 105(2):170-181. PubMed ID: 27829249
[TBL] [Abstract][Full Text] [Related]
8. Over-expression of decoy receptor 3 in gastric precancerous lesions and carcinoma.
Chen G; Luo D
Ups J Med Sci; 2008; 113(3):297-304. PubMed ID: 18991242
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of decoy receptor 3 in hepatocellular carcinoma and its association with resistance to Fas ligand-mediated apoptosis.
Shen HW; Gao SL; Wu YL; Peng SY
World J Gastroenterol; 2005 Oct; 11(38):5926-30. PubMed ID: 16273601
[TBL] [Abstract][Full Text] [Related]
10. Specific elevation of DcR3 in sera of sepsis patients and its potential role as a clinically important biomarker of sepsis.
Kim S; Mi L; Zhang L
Diagn Microbiol Infect Dis; 2012 Aug; 73(4):312-7. PubMed ID: 22647538
[TBL] [Abstract][Full Text] [Related]
11. Decoy receptor 3 overexpression and immunologic tolerance in hepatocellular carcinoma (HCC) development.
Chen C; Zhang C; Zhuang G; Luo H; Su J; Yin P; Wang J
Cancer Invest; 2008 Dec; 26(10):965-74. PubMed ID: 19093253
[TBL] [Abstract][Full Text] [Related]
12. Effects of miR-340 on hepatocellular carcinoma by targeting the DcR3 gene.
Xie L; Chen Z; Liu H; Guan L; Wang Z; Li W
Dig Liver Dis; 2018 Mar; 50(3):291-296. PubMed ID: 29311025
[TBL] [Abstract][Full Text] [Related]
13. Serum decoy receptor 3 is a biomarker for disease severity in nonatopic asthma patients.
Chen MH; Kan HT; Liu CY; Yu WK; Lee SS; Wang JH; Hsieh SL
J Formos Med Assoc; 2017 Jan; 116(1):49-56. PubMed ID: 26911723
[TBL] [Abstract][Full Text] [Related]
14. Serum decoy receptor 3 (DcR3): a promising biomarker for atopic asthma in children.
Kamal A; Abdelmegeid AK; Gabr MAM; Basanti CWS
Immunol Res; 2021 Dec; 69(6):568-575. PubMed ID: 34383195
[TBL] [Abstract][Full Text] [Related]
15. Expression and Clinical Significance of Decoy Receptor 3 in Acute-on-Chronic Liver Failure.
Lin S; Wu B; Lin Y; Wang M; Zhu Y; Jiang J; Zhang L; Lin J
Biomed Res Int; 2019; 2019():9145736. PubMed ID: 31317042
[TBL] [Abstract][Full Text] [Related]
16. Serum and synovial fluid levels of tumor necrosis factor-like ligand 1A and decoy receptor 3 in rheumatoid arthritis.
Xiu Z; Shen H; Tian Y; Xia L; Lu J
Cytokine; 2015 Apr; 72(2):185-9. PubMed ID: 25647275
[TBL] [Abstract][Full Text] [Related]
17. Decoy receptor 3 is highly expressed in patients with rheumatoid arthritis.
Hayashi S; Miura Y; Tateishi K; Takahashi M; Kurosaka M
Mod Rheumatol; 2010 Feb; 20(1):63-8. PubMed ID: 19821006
[TBL] [Abstract][Full Text] [Related]
18. [Association of serum decoy receptor 3 protein level with the clinicopathologic features of bladder transitional cell carcinoma].
Wang D; Wang J; Chen G
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Dec; 33(12):1831-2. PubMed ID: 24369256
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B X protein upregulates decoy receptor 3 expression via the PI3K/NF-κB pathway.
Liang DY; Sha S; Yi Q; Shi J; Chen Y; Hou Y; Chang Q
Cell Signal; 2019 Oct; 62():109346. PubMed ID: 31229617
[TBL] [Abstract][Full Text] [Related]
20. Serum decoy receptor 3 is a useful predictor for the active status of chronic hepatitis B in hepatitis B e antigen-negative patients.
Hou Y; Xu P; Lou X; Liang D; Zhang M; Zhang Z; Zhang L
Tohoku J Exp Med; 2013 Aug; 230(4):227-32. PubMed ID: 23925044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
